Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,958
-$29,300 QoQ
Shares Held
776
-54.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#225
of 290 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GROUP ONE TRADING LLC holds $113,695,832 across 200 Biotechnology names. DNLI ranks #113 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
203,915 | $14,280,167 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
261,443 | $10,198,891 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
272,609 | $6,564,424 | |
| 4 | ABSI |
Absci Corp
|
524,747 | $6,081,817 | |
| 5 | AGIO |
Agios Pharmaceuticals, Inc.
|
151,994 | $5,640,497 | |
| 6 | NKTR |
Nektar Therapeutics
|
70,371 | $4,912,599 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
85,040 | $4,638,081 | |
| 8 | ABVX |
Abivax S.A.
|
29,767 | $3,966,750 |
All Filings in DNLI
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,958 | 776 | Shares | Sole | 2026-08-14 | |
| 2024-09-30 | $49,258 | 1,691 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $173,496 | 8,455 | Shares | Sole | 2024-05-10 | |
| 2023-03-31 | $1,146,470 | 49,760 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $103,652 | 3,522 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $223,871 | 6,959 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $639,787 | 14,345 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $93,578 | 1,193 | Shares | Sole | 2021-08-10 | |
| 2020-03-31 | $100,787 | 5,756 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||